Drug Profile
Research programme: metabolic disorders therapy - OPi
Alternative Names: Metabolic disorders therapy research programme - OPi; OPM005Latest Information Update: 19 Feb 2008
Price :
$50
*
At a glance
- Originator OPi
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Metabolic disorders
Most Recent Events
- 17 May 2005 Preclinical trials in Metabolic disorders in France (unspecified route)